Literature DB >> 169259

Human phosphoribosylpyrophosphate synthetase. Comparison of purified normal and mutant enzymes.

M A Becker, P J Kostel, L J Meyer.   

Abstract

Human phosphoribosylpyrophosphate synthetase has been purified 4500-fold to electrophoretic homogeneity from the erythrocytes of normal individuals and of two brothers in whom excessive activity of this enzyme results in excessive rated of purine nucleotide and uric acid synthesis de novo and gouty arthritis. Structural differences between the normal and mutant enzymes are indicated by a lower isoelectric point for the mutant enzyme (pI 4.85) than for the normal enzyme (pI 5.10); decreased electrophoretic mobility of the mutant preparation on cellulose acetate gel at low inorganic phosphate concentrations; increased (2.4-fold) inactivation of the mutant enzyme activity relative to the normal by identical amounts of a specific antiserum which precipitates identical quantities of normal and mutant enzyme; increased thermal lability of the mutant enzyme at 55 degrees; and an increased (2.2-fold) specific enzyme activity for the mutant enzyme despite the comparable purity of the preparations. Antibody inactivation, quantitative precipitin, and immunodiffusion studies as well as the disparity in specific enzyme activities during the course of purification suggest that a structural alteration in the mutant enzyme leads to increased catalytic activity per enzyme molecule, either from a primary alteration in the structural gene(s) for phosphoribosylpyrophosphate synthetase or from a post-transcriptional alteration in the enzyme. Purified preparations of normal and mutant enzymes showed nearly identical affinity constants for magnesium and the substrates, ATP and ribose 5-phosphate, as well as similar inhibition constants for the products, PP-ribose-P and AMP, and the inhibitors ADP, GDP, and 2,3-diphosphoglycerate. An increased maximal velocity of the reaction was, thus, the sole kinetic difference identified. The increased velocity of the mutant enzyme reaction was constant over a range of inorganic phosphate concentrations from 0.1 to 100 mM. Subunit molecular weights of the enzyme preparations, estimated by sodium dodecyl sulfate-polyacrylamide electrophoresis, were identical (32,000), although the undenatured mutant enzyme showed a greater proportion of stainable protein in the smaller of two molecular weight forms (both greater than 500,000) of the enzyme demonstrated on polyacrylamide gel electrophoresis in the presence of 1 mM sodium phosphate.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 169259

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Recessive dystrophic epidermolysis bullosa: evidence for an altered collagenase in fibroblast cultures.

Authors:  E A Bauer
Journal:  Proc Natl Acad Sci U S A       Date:  1977-10       Impact factor: 11.205

2.  Evidence for X-linkage of human phosphoribosylpyrophosphate synthetase.

Authors:  R C Yen; W B Adams; C Lazar; M A Becker
Journal:  Proc Natl Acad Sci U S A       Date:  1978-01       Impact factor: 11.205

3.  Electrophoretic heterogeneity of 5-phosphoribosyl-1-pyrophosphate synthetase within and among humans.

Authors:  R V Lebo; D W Martin
Journal:  Biochem Genet       Date:  1978-10       Impact factor: 1.890

Review 4.  PRPS1 mutations: four distinct syndromes and potential treatment.

Authors:  Arjan P M de Brouwer; Hans van Bokhoven; Sander B Nabuurs; Willem Frans Arts; John Christodoulou; John Duley
Journal:  Am J Hum Genet       Date:  2010-04-09       Impact factor: 11.025

5.  Crystal structure of human phosphoribosylpyrophosphate synthetase 1 reveals a novel allosteric site.

Authors:  Sheng Li; Yongcheng Lu; Baozhen Peng; Jianping Ding
Journal:  Biochem J       Date:  2007-01-01       Impact factor: 3.857

6.  Patterns of phosphoribosylpyrophosphate and ribose-5-phosphate concentration and generation in fibroblasts from patients with gout and purine overproduction.

Authors:  M A Becker
Journal:  J Clin Invest       Date:  1976-02       Impact factor: 14.808

7.  Binding of cations in Bacillus subtilis phosphoribosyldiphosphate synthetase and their role in catalysis.

Authors:  Tine A Eriksen; Anders Kadziola; Sine Larsen
Journal:  Protein Sci       Date:  2002-02       Impact factor: 6.725

8.  The genetic and functional basis of purine nucleotide feedback-resistant phosphoribosylpyrophosphate synthetase superactivity.

Authors:  M A Becker; P R Smith; W Taylor; R Mustafi; R L Switzer
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

9.  Human skin collagenase in recessive dystrophic epidermolysis bullosa. Purification of a mutant enzyme from fibroblast cultures.

Authors:  G P Stricklin; H G Welgus; E A Bauer
Journal:  J Clin Invest       Date:  1982-06       Impact factor: 14.808

10.  Variant human phosphoribosylpyrophosphate synthetase altered in regulatory and catalytic functions.

Authors:  M A Becker; K O Raivio; B Bakay; W B Adams; W L Nyhan
Journal:  J Clin Invest       Date:  1980-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.